Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 04:08 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
NCT02174575 · Tokyo Medical and Dental University · PHASE4 · withdrawn · last registry update 2023-05-03 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “I retired my post before enrollment” | – | Registry record, Tokyo Medical and Dental University |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against GLRA1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2024-05-01Phase 3 first posted: Universitas Indonesia, Dexmedetomidine + Fentanyl (NCT06394375)
- 2024-04-18Also stopped (withdrawn): University Hospital, Geneva, Remifentanil + Sevoflurane (NCT02683837)
- 2024-04-05Results posted on the registry: Juntendo University, desflurane + propofol (NCT02324283)
- 2024-03-19Also stopped (terminated): Jan Jakobsson, a drug against GLRA1 (NCT02013869)
- 2024-02-21Phase 3 first posted: Nantes University Hospital, Carbocaine + Profofol and/or Suxaméthonium and/or Sévoflurane (NCT06271174)
- 2024-02-14Results posted on the registry: Stony Brook University, Aprepitant 80 mg Oral Capsule + scopolamine transdermal (NCT03435003)
- 2023-08-28Phase 3 first posted: Guy's and St Thomas' NHS Foundation Trust, Propofol + Isoflurane (NCT06014138)
- 2023-05-22Phase 3 first posted: Sunnybrook Health Sciences Centre, Isoflurane Inhalant Product (NCT05867472)
- 2023-05-09Phase 3 first posted: University Hospital, Clermont-Ferrand, Inhaled sedation with sevoflurane + Intravenous sedation (current practice) (NCT05849779)
- 2022-09-15Phase 3 first posted: Arash Afshari, Melatonin + Isotonic sodium chloride solution (NCT05541276)
- 2022-07-06Phase 3 first posted: Hospital for Special Surgery, New York, General anesthetic + SA + ESP (NCT05444751)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision